- Investor's Business Daily•14 hours ago
Amgen will likely beat Eli Lilly, Alder and Teva to market with an antibody-blocking migraine med.
- Market Realist•17 hours ago
Novo Nordisk has witnessed a modest YoY sales growth of ~7% in its US market, mainly due to rising sales of drugs like Tresiba, Victoza, and Saxenda.
Eli Lilly and Company (LLY)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||79.00 x 300|
|Ask||81.15 x 300|
|Day's Range||79.23 - 80.47|
|52wk Range||67.88 - 88.48|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||34.37|
|Avg Vol (3m)||3,444,567|
|Dividend & Yield||2.04 (2.53%)|